Thermo Fisher Scientific TMO Europe — Consolidated revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Thermo Fisher Scientific's europe — consolidated revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Thermo Fisher Scientific's europe — consolidated revenues?
- Thermo Fisher Scientific (TMO) reported europe — consolidated revenues of $2.96B in Q1 2026.
- How has Thermo Fisher Scientific's europe — consolidated revenues changed year-over-year?
- Thermo Fisher Scientific's europe — consolidated revenues increased by 12.7% year-over-year, from $2.62B to $2.96B.
- What is the long-term trend for Thermo Fisher Scientific's europe — consolidated revenues?
- Over 4 years (2021 to 2025), Thermo Fisher Scientific's europe — consolidated revenues has grown at a 1.5% compound annual growth rate (CAGR), from $11.13B to $11.83B.
- What does europe — consolidated revenues mean?
- The total sales revenue generated by the company's business activities within the European market.
- How do you interpret europe — consolidated revenues?
- An increase indicates growing market share or rising demand for scientific and laboratory solutions in Europe, while a decrease may signal regional economic headwinds or increased competitive pressure.
- How does europe — consolidated revenues compare across companies?
- Peers in the life sciences and diagnostics industry typically report regional revenues to highlight geographic diversification and exposure to specific healthcare regulatory environments.